ATE453397T1 - Probiotische tablettenformulierungen - Google Patents

Probiotische tablettenformulierungen

Info

Publication number
ATE453397T1
ATE453397T1 AT04804142T AT04804142T ATE453397T1 AT E453397 T1 ATE453397 T1 AT E453397T1 AT 04804142 T AT04804142 T AT 04804142T AT 04804142 T AT04804142 T AT 04804142T AT E453397 T1 ATE453397 T1 AT E453397T1
Authority
AT
Austria
Prior art keywords
zone
organism
probiotic
micro
probiotic micro
Prior art date
Application number
AT04804142T
Other languages
English (en)
Inventor
Kristian Henriksen
Helene Mortensen
Marianne Winning
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30776514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE453397(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrosan As filed Critical Ferrosan As
Application granted granted Critical
Publication of ATE453397T1 publication Critical patent/ATE453397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT04804142T 2003-12-24 2004-12-21 Probiotische tablettenformulierungen ATE453397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0330009.2A GB0330009D0 (en) 2003-12-24 2003-12-24 Probiotic tablet formulations
PCT/EP2004/014545 WO2005063200A2 (en) 2003-12-24 2004-12-21 Probiotic tablet formulations

Publications (1)

Publication Number Publication Date
ATE453397T1 true ATE453397T1 (de) 2010-01-15

Family

ID=30776514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04804142T ATE453397T1 (de) 2003-12-24 2004-12-21 Probiotische tablettenformulierungen

Country Status (15)

Country Link
US (2) US10172793B2 (de)
EP (1) EP1699474B2 (de)
CN (1) CN1913905B (de)
AT (1) ATE453397T1 (de)
AU (1) AU2004308632B2 (de)
CA (1) CA2551581A1 (de)
DE (1) DE602004024924D1 (de)
DK (1) DK1699474T4 (de)
EA (1) EA011321B1 (de)
ES (1) ES2336680T5 (de)
GB (1) GB0330009D0 (de)
NO (1) NO340908B1 (de)
PL (1) PL1699474T5 (de)
UA (1) UA87296C2 (de)
WO (1) WO2005063200A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1885383B1 (de) 2005-05-31 2016-09-21 IAMS Europe B.V. Katzen probiotisches bifidobacterium
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
EA014825B1 (ru) * 2005-09-29 2011-02-28 Мерк Патент Гмбх Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
AU2012244263B2 (en) * 2005-10-12 2015-09-17 Genencor International, Inc. Stable, durable granules with active agents
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US20080241805A1 (en) 2006-08-31 2008-10-02 Q-Track Corporation System and method for simulated dosimetry using a real time locating system
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CN101259278B (zh) * 2008-04-21 2010-06-02 黄芝芳 一种含抑菌剂的多种水溶性维生素的药物组合物及其制备方法
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2210593A3 (de) * 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettierbare Formulierungen von Vitamin A und Derivate davon
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR101102364B1 (ko) * 2009-09-18 2012-01-03 한림제약(주) 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물
US20120107395A1 (en) * 2010-11-01 2012-05-03 Viva Pharmaceutical Inc. Probiotic Soft Gel Compositions
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
DE102011122250A1 (de) * 2011-10-24 2013-04-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
CN106794202B (zh) 2014-05-12 2019-06-21 百通生物技术公司 改善人类皮肤健康的组合物及其在制备产品中的用途
CA2951739C (en) * 2014-07-01 2023-09-19 Tntgamble, Inc. Bi-layer dual release probiotic tablets
CN104489646B (zh) * 2014-11-19 2016-08-31 李雅君 一种果蔬益生菌片剂及其制备方法
EP3294073B1 (de) 2015-05-11 2022-08-10 Mybiotics Pharma Ltd Systeme und verfahren zur züchtung eines biofilms von probiotischen bakterien auf festen partikeln zur kolonisation von bakterien im darm
JP7017849B2 (ja) * 2015-09-11 2022-02-09 シムライズ アーゲー 経口投与剤形
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
EP3359173A1 (de) * 2015-10-07 2018-08-15 Bifodan A/S Probiotische formulierung
HK1257130A1 (zh) * 2015-10-16 2019-10-11 Novex Science Pte Limited 维生素c和锌片剂的稳定组合物
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
CN105962376A (zh) * 2016-04-28 2016-09-28 内蒙古乌审召生态产业发展有限公司 一种具有层结构的螺旋藻片及其制备方法
RU2022101485A (ru) 2016-05-25 2022-04-27 Майбиотикс Фарма Лтд. Композиция и способы для микробиотной терапии
PH12019500575B1 (en) 2016-11-10 2024-04-17 Socia‰Ta‰ Des Produits Nestla‰ S A Composition in powder form comprising iron and probiotic bacteria
EP3554264B1 (de) * 2016-12-15 2025-03-19 Société des Produits Nestlé S.A. Verfahren zur herstellung einer pulverförmigen zusammensetzung enthaltend eisen-milchprotein-komplexe und probiotische bakterien, wobei das milchprotein casein, ein caseinderivat, eine caseinfraktion oder mischungen davon ist sowie rekonstitution desselben
IT201700011337A1 (it) * 2017-02-02 2018-08-02 S I I T S R L Servizio Int Imballaggi Termosaldanti Compressa multistrato per la somministrazione di magnesio
CN107821753A (zh) * 2017-11-20 2018-03-23 江苏雅博动物健康科技有限责任公司 一种宠物用益生菌颗粒制剂及其制备方法
JP2021504327A (ja) * 2017-11-27 2021-02-15 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 凍結乾燥多粒子固形製剤
CA3096300A1 (en) 2018-05-29 2019-12-05 BiOWiSH Technologies, Inc. Compositions and methods for improving survivability of aquatic animals
US11247944B2 (en) 2019-04-12 2022-02-15 Jeffrey Hanson Robbins Potassium citrate mixture formed from a dry fertilizer and methods thereof
US11254619B2 (en) 2019-04-12 2022-02-22 Jeffrey Hanson Robbins Dry composition including effervescent agents, biostimulant, and plant nutrient
SG11202110641XA (en) * 2019-04-15 2021-10-28 Inst Dinvestigacions Biomediques August Pi I Sunyer Idibaps Long-term stable live fecal microbiota composition
CN110934751B (zh) * 2019-12-31 2022-09-02 成都三勒浆药业集团四川华美制药有限公司 一种用于口腔健康的双层口含片及其制备方法
FR3125945B1 (fr) * 2021-08-03 2024-07-12 Setalg Composition pour protéger un microorganisme dans un environnement acide.
GR1010840B (el) * 2023-10-02 2024-12-18 Geoplan Nutraceuticals Ike, Συνθεσεις στοματικα διασπειρομενων δισκιων με προβιοτικα, ψευδαργυρο και βιταμινη c

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
DE3369829D1 (en) † 1983-02-18 1987-04-02 Nabisco Brands Inc Canine biscuit containing discrete meat and/or meat by-product particles and method for making same
US4956295A (en) † 1984-05-21 1990-09-11 Chr. Hansen's Laboratory, Inc. Stabilization of dried bacteria extended in particulate carriers
JPH0780754B2 (ja) * 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US5310555A (en) † 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5885481A (en) 1993-07-16 1999-03-23 Amoco Corporation Efficiency oxygen-scavenging compositions and articles
FR2716341B1 (fr) † 1994-02-23 1996-05-10 Gervais Danone Sa Composition alimentaire comportant un biscuit ou une coque de chocolat et un fourrage à base de produit laitier, fermenté ou non .
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
SE513815C2 (sv) 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet
US5774056A (en) 1996-05-30 1998-06-30 Engineered Products Co. Gauge for monitoring air filters
US6083585A (en) 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
GB2323532B (en) * 1997-03-27 2001-08-22 Bakulesh Mafatlal Khamar Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
ES2173372T3 (es) * 1997-12-19 2002-10-16 Merck Patent Gmbh Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias.
US6169387B1 (en) 1997-12-22 2001-01-02 Lifecor, Inc. Battery management apparatus for portable electronic devices
PT956858E (pt) 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
DE19819475A1 (de) * 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
EP1102595A2 (de) 1998-08-07 2001-05-30 Ganeden Biotech, Inc. Methoden zur erhöhung der löslichkeit von nahrungsstoffen mit probiotisch wirksamen milchsäure-produzierenden bakterien
DE69932030T2 (de) † 1999-04-09 2007-01-04 Société des Produits Nestlé S.A. Roher belegter Pizzateig
CA2281463A1 (en) 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
SE515310C2 (sv) 1999-11-25 2001-07-09 Wasa Medicals Ab Tabletter innehållande mikroorganismer och förfarande för framställning därav
US6399114B2 (en) 2000-05-26 2002-06-04 C & D Foreman, Inc. Nutritional system for nervous system disorders
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
JP5041651B2 (ja) 2001-09-28 2012-10-03 ティーエヌティーギャンブル・インコーポレーテッド 生物体成分の送達系
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE10206995B4 (de) 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
DE20202562U1 (de) 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
EP1344458A1 (de) † 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. System zur Verabreichung von Probiotika
WO2003080813A2 (en) 2002-03-21 2003-10-02 Bifodan A/S Lactobacillus strains
EP1449525A1 (de) * 2003-02-20 2004-08-25 Cross Chem Llc Kaugummi in der Form von Mehrschichttabletten
US9210945B2 (en) † 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
EP2464245B1 (de) † 2009-08-13 2018-10-31 Kellogg Company Lebensmittelbinder mit geringer wasseraktivität und zugehörige verfahren

Also Published As

Publication number Publication date
EP1699474B2 (de) 2013-10-23
EA011321B1 (ru) 2009-02-27
UA87296C2 (en) 2009-07-10
NO20063410L (no) 2006-09-22
CN1913905A (zh) 2007-02-14
US10172793B2 (en) 2019-01-08
US20070269515A1 (en) 2007-11-22
DK1699474T4 (da) 2013-12-02
WO2005063200A3 (en) 2005-11-24
CN1913905B (zh) 2010-09-08
US20190091145A1 (en) 2019-03-28
CA2551581A1 (en) 2005-07-14
AU2004308632B2 (en) 2010-07-01
PL1699474T3 (pl) 2010-06-30
AU2004308632A1 (en) 2005-07-14
PL1699474T5 (pl) 2014-02-28
EA200601214A1 (ru) 2006-12-29
DK1699474T3 (da) 2010-04-12
DE602004024924D1 (de) 2010-02-11
ES2336680T5 (es) 2014-01-20
ES2336680T3 (es) 2010-04-15
NO340908B1 (no) 2017-07-10
WO2005063200A2 (en) 2005-07-14
EP1699474A2 (de) 2006-09-13
EP1699474B1 (de) 2009-12-30
GB0330009D0 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
DK1699474T4 (da) Probiotiske tabletformuleringer
Wu et al. Effect of probiotic Bacillus subtilis Ch9 for grass carp, Ctenopharyngodon idella (Valenciennes, 1844), on growth performance, digestive enzyme activities and intestinal microflora
DK0973413T3 (da) Levnedsmiddelformuleringer indeholdende lacto-N-neotetraose
AU7038600A (en) Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
PH12013501474A1 (en) Local topical administration formulations containing indoxacarb
DE60133581D1 (de) Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
HUP0104782A2 (hu) Eljárás állatkedvencek aktivitásának fokozására
DE60205646D1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
DK2288360T3 (da) Isoleret Lactobacillus plantarum-stamme Inducia DSM21379 som probiotikum, som forøger naturlig immunitet, samt fødevareprodukter og medicinske præparater omfattende den
DK1408776T3 (da) Hidtil ukendte levnedsmiddelprodukter indeholdende betain
DK1411960T3 (da) Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
ATE335807T1 (de) Neuer stamm von milchsäurebakterien und diesen enthaltende essbare zusammensetzungen, wirkstoffe und tierische arzneimittel
NO20054765L (no) Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
AR025320A1 (es) Composicion liquida para mejorar el pan
TW200700074A (en) Inducer of t cell apoptosis
DE602005018237D1 (de) Zusammensetzung mit immunregulierenden wirkungen aus lactobacillus pentosus
DE502005010277D1 (de) Teinen
CA2427080A1 (en) Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation
TW200509794A (en) Novel anthelmintic and insecticidal compositions
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
ATE285757T1 (de) Inaktivierte mikroorganismen, die pharmakologisch aktive substanzen enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties